Description
An endogenous mineralocorticoid; a metabolite of progesterone and precursor to aldosterone and corticosterone; metabolized to the neuroactive compound THDOC, which positively modulates GABAA receptors and produces effects similar to barbiturates in rats; levels increase following naloxone or CRH injection in cynomolgus monkeys; levels decrease following dexamethasone administration; increased 3.4-fold in obese and diabetic mice
Formal name: 21-hydroxy-pregn-4-ene-3,20-dione
Synonyms: 21-hydroxy Progesterone|DOC|NSC 11319
Molecular weight: 330.5
CAS: 64-85-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Glucocorticoids & Mineralocorticoids||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity||Research Area|Neuroscience|Neuroendocrinology